Infectious Disease Alert – November 1, 2011
November 1, 2011
View Issues
-
Abstract & Commentary: Otoscopic Signs of Otitis Media
A total of 783 children 6-24 months of age were followed for an entire respiratory season by four experienced otoscopists using pneumatic otoscopy of one ear, randomly selected for each child. -
Abstract & Commentary: Necrotizing Pneumococcal Pneumonia in Children due to Streptococcus pneumoniae
This study was conducted at the largest children's hospital in Taiwan. All pneumococcal isolates recovered from sterile sites from children hospitalized at this institution were maintained frozen at -20° C since 2000. -
Abstract & Commentary: Effect of an Oxazolidinone and Clindamycin on Staphylococcus aureus Virulence Factors
Baseline production of PSMa subtypes was examined in 50 PVL-positive methicillin-susceptible Staphylococcus aureus (MSSA) and MRSA clinical isolates using liquid chromatography-tandem mass spectrometry (LC-MS-MS), and these results were compared to a control strain, LAC (USA300). MICs were determined using a broth macrodilution method. -
Abstract & Commentary: Movies and Politicians: Which Are Reality-based?
Hollywood movies have always created their own reality. Meanwhile, the rest of us slog through the conventional reality of our daily lives. -
Abstract & Commentary: Clostridium difficile BI: From Canada to the Second City
A 1-month prevalence study was done in 2009 at 25 of the 56 contributing hospitals participating in the Chicago Health Alert Network. -
Abstract & Commentary: HIV-1 Protein, Nef, Contributes to Insulin Resistance
While a number of antiretroviral agents have been implicated in contributing to both insulin resistance and lipid abnormalities, HIV also directly causes metabolic disturbances. -
Abstract & Commentary: Moxifloxacin for Odontogenic Infection
Outpatients with a diagnosis of either dentoalveolar or periodontal abscess or a diagnosis of gingival inflammatory infiltrates were randomized to receive either moxifloxacin 400 mg daily or clindamycin 300 mg QID, both for 5 days, in a prospective, randomized, placebo-controlled, double-dummy clinical trial design. -
Abstract & Commentary: Intravenous Immune Globulin for Neonatal Sepsis
A double-blind, randomized, controlled trial conducted by the International Neonatal Immunotherapy Study (INIS) compared adjunctive therapy of human nonspecific polyvalent IgG intravenous immune globulin to placebo in the treatment of newborn infants with suspected or proven sepsis who were also receiving antibiotic therapy. -
Updates By Carol A. Kemper, MD, FACP
In early October, 12 inmates from the Utah State Correctional Facility became acutely ill with nausea, vomiting, facial paralysis, and visual blurring. -
Pharmacology Watch: Medication Poisonings Are Increasing in Children
In this issue: Medication poisonings in children; rosuvastatin vs atorvastatin for atherosclerosis; saw palmetto for prostate symptoms; using atypical antipsychotics for off-label indications in adults; and FDA actions. -
Clinical Briefs in Primary Care supplement